"We are absolutely realistic that due to geopolitical restrictions, supplies to the United States and Europe will be limited, although we could also supply allergy sufferers," Dmitriev said.
He said that "we will move gradually with European countries, for us the main markets are Latin America, the Middle East, Asia and Africa."
Earlier it was reported that vaccination against coronavirus with the Russian drug "Sputnik V" began in Argentina.
Argentine President Alberto Fernandez expressed his gratitude for the delivery of a consignment of Sputnik V coronavirus vaccine to the country.